BYSI
Price
$0.80
Change
-$0.01 (-1.23%)
Updated
Oct 2, 04:42 PM (EDT)
Capitalization
46.05M
76 days until earnings call
Intraday BUY SELL Signals
XRTX
Price
$1.71
Change
-$0.02 (-1.16%)
Updated
Oct 2, 04:55 PM (EDT)
Capitalization
3.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

BYSI vs XRTX

BYSI vs XRTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BYSI vs. XRTX commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BYSI is a Hold and XRTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BYSI vs XRTX: Fundamental Ratings
BYSI
XRTX
OUTLOOK RATING
1..100
4297
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6586
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BYSI's Valuation (46) in the Pharmaceuticals Major industry is in the same range as XRTX (57) in the null industry. This means that BYSI’s stock grew similarly to XRTX’s over the last 12 months.

BYSI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as XRTX (100) in the null industry. This means that BYSI’s stock grew similarly to XRTX’s over the last 12 months.

BYSI's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as XRTX (99) in the null industry. This means that BYSI’s stock grew similarly to XRTX’s over the last 12 months.

BYSI's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as XRTX (86) in the null industry. This means that BYSI’s stock grew similarly to XRTX’s over the last 12 months.

XRTX's P/E Growth Rating (66) in the null industry is somewhat better than the same rating for BYSI (100) in the Pharmaceuticals Major industry. This means that XRTX’s stock grew somewhat faster than BYSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BYSIXRTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (BYSI: $0.81 vs. XRTX: $1.73)
Brand notoriety: BYSI and XRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BYSI: 4% vs. XRTX: 6%
Market capitalization -- BYSI: $46.05M vs. XRTX: $3.09M
BYSI [@Biotechnology] is valued at $46.05M. XRTX’s [@Biotechnology] market capitalization is $3.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BYSI’s FA Score shows that 0 FA rating(s) are green while XRTX’s FA Score has 0 green FA rating(s).

  • BYSI’s FA Score: 0 green, 5 red.
  • XRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BYSI is a better buy in the long-term than XRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BYSI’s TA Score shows that 3 TA indicator(s) are bullish while XRTX’s TA Score has 5 bullish TA indicator(s).

  • BYSI’s TA Score: 3 bullish, 5 bearish.
  • XRTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XRTX is a better buy in the short-term than BYSI.

Price Growth

BYSI (@Biotechnology) experienced а +12.23% price change this week, while XRTX (@Biotechnology) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

BYSI is expected to report earnings on Dec 17, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BYSI
Daily Signal:
Gain/Loss:
XRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLDE23.631.32
+5.92%
Slide Insurance Holdings Inc
PTC146.476.17
+4.40%
PTC
ETD21.160.25
+1.20%
Ethan Allen Interiors
MBOT1.20N/A
N/A
Microbot Medical
TGL1.37-0.06
-4.53%
Treasure Global Inc.

BYSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with GOSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
+5.68%
GOSS - BYSI
38%
Loosely correlated
-7.76%
CYTK - BYSI
37%
Loosely correlated
-0.44%
VNDA - BYSI
33%
Poorly correlated
-2.04%
TAOX - BYSI
31%
Poorly correlated
-3.09%
RCUS - BYSI
31%
Poorly correlated
-2.32%
More

XRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with BCDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
+2.37%
BCDA - XRTX
43%
Loosely correlated
+0.99%
KPRX - XRTX
30%
Poorly correlated
+0.78%
BYSI - XRTX
26%
Poorly correlated
+5.68%
CLNN - XRTX
26%
Poorly correlated
-1.47%
MIST - XRTX
26%
Poorly correlated
-5.78%
More